Alchem

Alchem, officially Alchem Laboratories Corporation, is a specialty contract research and manufacturing organization (CRO/CMO) that provides custom synthesis, drug development, and cGMP manufacturing services. Based in Alachua, Florida, the company specializes in small molecule synthesis and the production of clinical trial materials, supporting over 20 active clinical studies including programs in Phase 3. In early 2026, Alchem gained significant prominence through a strategic alliance with the Mark Cuban Cost Plus Drug Company and Applied Pharmaceutical Innovation to develop a portfolio of 86 essential medicines aimed at securing the pharmaceutical supply chain and addressing drug shortages. The company leverages an AI/ML platform, developed in collaboration with University of Florida researchers, to optimize drug discovery and manufacturing processes. Alchem operates as a subsidiary of TRON Group and maintains multiple cGMP facilities dedicated to the rapid development and onshoring of critical therapies.